indications for glp 1 agonists GLP-1 Drugs: Where We Are and Where We're Going — Summit Re GLP-1 Agonists Market Report 2025-2033,

These are considered to be serious health conditions that increase the risk for premature death, heart attack, stroke and other health issues (FDA News Release March 8, 2024)

19 In regard to CKD, these clinical trials have also shown positive effects in the composite renal outcomes

[DOI] [PubMed] [Google Scholar]

While Semaglutide GLP-1 injections are a helpful tool for managing weight, they are not appropriate for everyone

FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults With Obesity or Overweight

People need to know from the start that these are prescribed as long-term medications for their effect on body weight, glucose levels, and potentially cardiovascular protection, Pratley says, adding that people dont stop antihypertensives or statins because they achieve or reach normal blood pressure or LDL cholesterol levels, respectively